Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors

This study has been terminated.
(insufficient accrual)
Information provided by:
Neurological Surgery, P.C. Identifier:
First received: February 19, 2009
Last updated: July 15, 2010
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)